Landscapes / Targets
MUC16
5 drugs act on MUC16, in 10 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 3 | 26 Dec 2026Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 26 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Ovarian Cancer, Ovarian Serous Adenocarcinoma and 18 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Regeneron · Public REGN |
Phase 2 | 10 May 2027Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 10 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Endometrial Cancer, Ovarian Cancer and 11 more | ||||
| Open drug page | |||||
— |
Regeneron · Public REGN |
Phase 1/2 | 8 Nov 2028Phase 1/2 trial completes | ||
| Next date | 8 Nov 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer, Fallopian Tube Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2028Phase 1 trial completes | |||
| Next date | Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | PROC, Platinum Resistant Ovarian Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma and 32 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026